Camlin Fine Sciences Ltd. | Mid-cap | Basic Materials
₹324.08
4.62%
| Camlin Fine Sciences Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 16.7B
Gross Profit 8.2B 49.04%
Operating Income 1.4B 8.66%
Net Income -1.6B -9.49%

Balance Sheet Metrics

Total Assets 20.2B
Total Liabilities 11.5B
Shareholders Equity 8.7B
Debt to Equity 1.31

Cash Flow Metrics

Operating Cash Flow -1.4B
Free Cash Flow -157.2M

Revenue & Profitability Trend

Camlin Fine Sciences Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 16.7B 16.0B 16.7B 14.0B 11.7B
Cost of Goods Sold 8.5B 9.4B 8.3B 7.7B 5.9B
Gross Profit 8.2B 6.6B 8.4B 6.3B 5.8B
Operating Expenses 4.2B 3.2B 4.4B 3.1B 2.5B
Operating Income 1.4B 713.3M 1.6B 1.1B 1.6B
Pre-tax Income 494.7M -992.4M 803.8M 939.8M 1.1B
Income Tax 665.0K 56.3M 405.7M 336.1M 397.4M
Net Income -1.6B -1.0B 398.1M 603.7M 653.6M
EPS (Diluted) - -₹5.45 ₹3.41 ₹4.53 ₹3.68

Income Statement Trend

Camlin Fine Sciences Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 11.8B 10.0B 10.9B 8.9B 7.9B
Non-Current Assets 8.4B 9.5B 9.7B 9.1B 6.9B
Total Assets 20.2B 19.5B 20.6B 18.0B 14.8B
Liabilities
Current Liabilities 8.5B 7.3B 7.9B 6.0B 4.8B
Non-Current Liabilities 3.0B 3.6B 4.4B 4.4B 2.9B
Total Liabilities 11.5B 10.9B 12.4B 10.4B 7.7B
Equity
Total Shareholders Equity 8.7B 8.6B 8.2B 7.7B 7.1B

Balance Sheet Composition

Camlin Fine Sciences Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income -1.6B -992.4M 803.8M 939.8M 1.1B
Operating Cash Flow -1.4B 271.7M -157.0M 1.4B 847.3M
Investing Activities
Capital Expenditures -424.5M -600.2M -1.4B -2.1B -838.7M
Investing Cash Flow -424.5M -600.2M -1.4B -2.8B -838.7M
Financing Activities
Dividends Paid - -281.3M -138.5M -7.1M -54.2M
Financing Cash Flow 2.1B -273.7M 389.7M 637.0M 37.3M
Free Cash Flow -157.2M 784.1M -934.1M -683.4M 335.1M

Cash Flow Trend

Camlin Fine Sciences Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 105.59
Forward P/E 27.30
Price to Book 6.08
Price to Sales 3.42

Profitability Ratios

Profit Margin -8.34%
Operating Margin 9.38%
Return on Equity 5.71%
Return on Assets 4.54%

Financial Health

Current Ratio 1.40
Debt to Equity 77.88
Beta 0.50

Per Share Data

EPS (TTM) ₹2.87
Book Value per Share ₹49.82
Revenue per Share ₹96.24

Financial data is updated regularly. All figures are in the company's reporting currency.